{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:21:24Z","timestamp":1790508084493,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health (NIH)","doi-asserted-by":"crossref","award":["P01 AI060915"],"award-info":[{"award-number":["P01 AI060915"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health (NIH)","doi-asserted-by":"crossref","award":["R56 AI089535"],"award-info":[{"award-number":["R56 AI089535"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Analytical Biochemistry"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.ab.2012.01.006","type":"journal-article","created":{"date-parts":[[2012,1,18]],"date-time":"2012-01-18T10:04:00Z","timestamp":1326881040000},"page":"46-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Reducing agents affect inhibitory activities of compounds: Results from multiple drug targets"],"prefix":"10.1016","volume":"423","author":[{"given":"Hyun","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Truong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rima","family":"Chaudhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ab.2012.01.006_b0005","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nprot.2006.77","article-title":"A detergent-based assay for the detection of promiscuous inhibitors","volume":"1","author":"Feng","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ab.2012.01.006_b0010","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1089\/adt.2007.066","article-title":"Development and implementation of a 384-well homogeneous fluorescence intensity high-throughput screening assay to identify mitogen-activated protein kinase phosphatase-1 dual-specificity protein phosphatase inhibitors","volume":"5","author":"Johnston","year":"2007","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.ab.2012.01.006_b0015","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/nprot.2007.155","article-title":"Development and optimization of high-throughput in vitro protein phosphatase screening assays","volume":"2","author":"Tierno","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ab.2012.01.006_b0020","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1177\/1087057107304113","article-title":"A simple assay for detection of small-molecule redox activity","volume":"12","author":"Lor","year":"2007","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.ab.2012.01.006_b0025","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1124\/mol.105.016360","article-title":"Redox regulation of Cdc25B by cell-active quinolinediones","volume":"68","author":"Brisson","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ab.2012.01.006_b0030","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1089\/adt.2008.151","article-title":"Development of a 384-well colorimetric assay to quantify hydrogen peroxide generated by the redox cycling of compounds in the presence of reducing agents","volume":"6","author":"Johnston","year":"2008","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.ab.2012.01.006_b0035","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1006\/abbi.2002.2757","article-title":"Expression, preparation, and high-throughput screening of caspase-8: discovery of redox-based and steroid diacid inhibition","volume":"399","author":"Smith","year":"2002","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ab.2012.01.006_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2007.03.056","article-title":"High throughput screening for small molecule inhibitors of heparin-induced tau fibril formation","volume":"358","author":"Crowe","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ab.2012.01.006_b0045","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.abb.2004.05.010","article-title":"The oxidative mechanism of action of ortho-quinone inhibitors of protein\u2013tyrosine phosphatase alpha is mediated by hydrogen peroxide","volume":"429","author":"Bova","year":"2004","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ab.2012.01.006_b0050","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1039\/b806712k","article-title":"Computational design, synthesis, and biological evaluation of para-quinone-based inhibitors for redox regulation of the dual-specificity phosphatase Cdc25B","volume":"6","author":"Keinan","year":"2008","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ab.2012.01.006_b0055","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1089\/adt.2009.0247","article-title":"Profiling the NIH small molecule repository for compounds that generate H2O2 by redox cycling in reducing environments","volume":"8","author":"Soares","year":"2010","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.ab.2012.01.006_b0060","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1177\/1087057106289231","article-title":"Screening for caspase-3 inhibitors: effect of a reducing agent on identified hit chemotypes","volume":"11","author":"Okun","year":"2006","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.ab.2012.01.006_b0065","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/hep.20819","article-title":"Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes","volume":"42","author":"Simmonds","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.ab.2012.01.006_b0070","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1462-5822.2007.01107.x","article-title":"Early steps of the hepatitis C virus life cycle","volume":"10","author":"Dubuisson","year":"2008","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.ab.2012.01.006_b0075","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nature05654","article-title":"Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry","volume":"446","author":"Evans","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ab.2012.01.006_b0080","doi-asserted-by":"crossref","first-page":"12465","DOI":"10.1128\/JVI.01457-07","article-title":"Claudin-6 and claudin-9 function as additional coreceptors for hepatitis C virus","volume":"81","author":"Zheng","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.ab.2012.01.006_b0085","doi-asserted-by":"crossref","first-page":"e1866","DOI":"10.1371\/journal.pone.0001866","article-title":"The CD81 partner EWI-2wint inhibits hepatitis C virus entry","volume":"3","author":"Rocha-Perugini","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.ab.2012.01.006_b0090","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.2174\/138161206779010369","article-title":"Drug design targeting the main protease, the Achilles\u2019 heel of coronaviruses","volume":"12","author":"Yang","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ab.2012.01.006_b0095","first-page":"57","article-title":"The coronavirus replicase","volume":"287","author":"Ziebuhr","year":"2005","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.ab.2012.01.006_b0100","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1002\/hep.1840360706","article-title":"Natural history of chronic hepatitis C","volume":"36","author":"Seeff","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.ab.2012.01.006_b0105","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0140-6736(03)13077-2","article-title":"Coronavirus as a possible cause of severe acute respiratory syndrome","volume":"361","author":"Peiris","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ab.2012.01.006_b0110","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMoa030781","article-title":"A novel coronavirus associated with severe acute respiratory syndrome","volume":"348","author":"Ksiazek","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ab.2012.01.006_b0115","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1056\/NEJMoa030747","article-title":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome","volume":"348","author":"Drosten","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ab.2012.01.006_b0120","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1021\/ci049714+","article-title":"ZINC\u2014a free database of commercially available compounds for virtual screening","volume":"45","author":"Irwin","year":"2005","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ab.2012.01.006_b0125","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s12033-010-9335-9","article-title":"Design and implementation of high throughput screening assays","volume":"47","author":"Macarron","year":"2011","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.ab.2012.01.006_b0130","doi-asserted-by":"crossref","first-page":"16007","DOI":"10.1074\/jbc.275.21.16007","article-title":"Potent and selective nonpeptide inhibitors of caspases 3 and 7 inhibit apoptosis and maintain cell functionality","volume":"275","author":"Lee","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ab.2012.01.006_b0135","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1021\/jm0100537","article-title":"Potent and selective nonpeptide inhibitors of caspases 3 and 7","volume":"44","author":"Lee","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ab.2012.01.006_b0140","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1021\/bi101504w","article-title":"Dithiothreitol causes HIV-1 integrase dimer dissociation while agents interacting with the integrase dimer interface promote dimer formation","volume":"50","author":"Tsiang","year":"2011","journal-title":"Biochemistry"}],"container-title":["Analytical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003269712000280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003269712000280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T21:04:19Z","timestamp":1757711059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003269712000280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0003269712000280"],"URL":"https:\/\/doi.org\/10.1016\/j.ab.2012.01.006","relation":{},"ISSN":["0003-2697"],"issn-type":[{"value":"0003-2697","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reducing agents affect inhibitory activities of compounds: Results from multiple drug targets","name":"articletitle","label":"Article Title"},{"value":"Analytical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ab.2012.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}